The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index; 25 of the 80 sources its claims cite were checked for support.
Apolipoprotein E–low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner
Open accessAbstract
Human apolipoprotein E (apoE) exists in three isoforms: apoE2, apoE3 and apoE4. APOE ε4 is a major genetic risk factor for cardiovascular disease (CVD) and Alzheimer's disease (AD). ApoE mediates cholesterol metabolism by binding various receptors. The low-density lipoprotein receptor (LDLR) has a high affinity for apoE, and is the only member of its receptor family to demonstrate an apoE isoform specific binding affinity (E4>E3>>E2). Evidence suggests that a functional interaction between apoE and LDLR influences the risk of CVD and AD. We hypothesize that the differential cognitive effects of the apoE isoforms are a direct result of their varying interactions with LDLR. To test this hypothesis, we have employed transgenic mice that express human apoE2, apoE3, or apoE4, and either human LDLR (hLDLR) or no LDLR (LDLR(-/-)). Our results show that plasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform-dependent interactions between apoE and LDLR. Conversely, both anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype, but these processes appear to occur via an LDLR-independent mechanism. Both the lack of LDLR and the interaction between E4 and the LDLR were associated with significant impairments in the retention of long term spatial memory. Finally, levels of hippocampal apoE correlate with long term spatial memory retention in mice with human LDLR. In summary, we demonstrate that the apoE-LDLR interaction affects regional brain apoE levels, brain cholesterol, and cognitive function in an apoE isoform-dependent manner.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In human apoE-targeted replacement mice, apoE–LDLR interaction regulates plasma and brain apoE levels and long-term spatial memory in an isoform-dependent manner, while anxiety-like behavior and cued fear memory are APOE-genotype effects independent of LDLR. Both LDLR absence and the E4–human LDLR combination impair long-term spatial memory retention.
Key findings
- Spatial memory retention depended on LDLR and APOE: LDLR−/− mice failed to prefer the target quadrant regardless of APOE genotype, while human LDLR E2 and E3 mice showed retention at 72 h (42.4 ± 18.1% and 40.7 ± 12.5% time in target quadrant), but E4 mice with human LDLR did not.
- Brain apoE levels were regulated by an APOE × LDLR interaction: with human LDLR, a pattern of E2 > E3 > E4 emerged across brain regions (APOE × LDLR effect, all regions p < 0.01), whereas LDLR−/− mice generally had similar regional apoE levels except higher cerebellar apoE in E2 than E3 or E4.
- Plasma apoE was markedly lowered by LDLR expression and differed by APOE genotype only with human LDLR: E2 mice had 20.3 ± 1.5 μg/ml versus 7.0 ± 0.9 μg/ml in E3 and 5.9 ± 0.5 μg/ml in E4.
- Anxiety-like behavior and cued associative memory were APOE-dependent but LDLR-independent: E4 mice spent less time in the elevated zero-maze open area (13.0 ± 3.6% without LDLR, 14.3 ± 4.2% with human LDLR) than E3 (18.6 ± 6.0%, 19.4 ± 6.1%) or E2 (24.5 ± 4.5%, 26.3 ± 8.9%), and cued freezing was E4 > E3 > E2 without a significant LDLR effect.
- In mice with human LDLR, hippocampal apoE correlated with 72 h spatial memory retention across isoforms (r² = 0.722, p < 0.001), but this correlation was absent in LDLR−/− mice (r² = 0.0065, p = 0.7502).
Methods
- Mice expressed human apoE2, apoE3, or apoE4 (targeted replacement) and either human LDLR (hemizygous) or no LDLR (LDLR−/−); all were on a C57BL/6 background, fed normal chow, and tested at 10–12 months of age (n = 6–12). Only female mice were used.
- Behavioral testing included elevated zero maze for anxiety, novel object recognition, Morris water maze for spatial learning/memory (visible and hidden platform training plus probe trials at 24 h and 72 h), and contextual/cued fear conditioning.
- Biochemical analyses measured plasma apoE by ELISA, regional brain apoE by Western blot, plasma and brain cholesterol by colorometric assay and GC, and LDLR expression by primer extension/real-time PCR; statistics used ANOVA/repeated measures ANOVA and two-tailed Pearson correlations.
Limitations
- Stated: the study used only female mice, and apoE isoform-specific sex differences in behavior have been previously shown.
- Stated: human LDLR expression in hemizygous mice ranged from 16–205% with a mean of 99% compared to murine LDLR in wild-type mice, and the authors focused on hemizygous rather than homozygous human LDLR mice.
- Stated: the hippocampal apoE–spatial memory relationship is correlative, so the possibility remains that the apoE isoform present, rather than overall apoE level, is the key determinant of spatial memory retention.
- Evident from the text: cortical and hippocampal cholesterol were not significantly affected by APOE genotype, with only a trend toward lower cortical cholesterol in human LDLR E4 mice, and brain cholesterol did not correlate with behavioral outcomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
25 of 80 cited sources checked · 18 supported · 0 flagged · accuracy not yet measured
- Premisecitation
The risk of Alzheimer's disease is modified by various LDLR polymorphisms.
“In the context of AD, the risk of disease is modified by various LDLR polymorphisms (Gopalraj et al., 2005, Zou et al., 2008).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Gopalraj et al., 2005 source
- cites Zou et al., 2008 source
The Results report increased Alzheimer’s disease risk for men with the LDLR rs688T/T genotype, but not for women. This paper establishes the association for one polymorphism under a sex-specific condition; it does not itself establish that various LDLR polymorphisms modify risk. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Several genetic studies have implicated the LDLR and the apoE-LDLR interaction as a disease modifying mechanism in AD.
“Still, several important genetic studies have implicated the LDLR – and the apoE-LDLR interaction – as a disease modifying mechanism in AD.”
Quote in the paperSubstantial claim1 of 3 sources checked - Premisecitation
In mice, the development of atherosclerosis is accelerated when human LDLR and E4 are combined in the background of diabetes.
“In addition, the development of atherosclerosis is accelerated in mice when human LDLR and E4 were combined in the background of diabetes (Johnson et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Johnson et al., 2013 source
- Premisecitation
Polymorphisms in LDLR exon 8 and exon 13 present in conjunction with an ε4 allele increase AD risk.
“Furthermore, studies by Retz et al. (2001) and Cheng et al. (2005) demonstrated an increase in AD risk when polymorphisms in LDLR exon 8 and exon 13 were present in conjunction with an ε4 allele.”
Quote in the paperNot a substantial claim1 of 2 sources checked - Interpretationreasoning
A functional interaction between apoE and LDLR is a potential mechanism to explain the apoE isoform-dependent disease risks associated with both CVD and AD.
“Together with epidemiological studies (Cheng et al., 2005, Gopalraj et al., 2005, Retz et al., 2001, Vermissen et al., 2011, Zou et al., 2008), these data point toward a functional interaction between apoE and LDLR as a potential mechanism to explain the apoE isoform-dependent disease risks associated with both CVD and AD.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Cheng et al., 2005 source
The Abstract concludes that the results imply a functional interaction between ApoE and LDL receptor proteins affecting Alzheimer’s disease (AD) risk, and the Discussion proposes that particular combinations may modify that risk. The paper discusses cholesterol metabolism but does not connect the interaction to cardiovascular disease (CVD) risk, so it supports the AD portion, not the claim about both diseases. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Gopalraj et al., 2005 source
- cites Retz et al., 2001 source
- Premisecitation
Increasing LDLR expression in the presence of apoE4 has harmful effects in a mouse model of CVD.
“Given the harmful effects of increasing LDLR expression in the presence of apoE4 in a mouse model of CVD (Altenburg et al., 2007, Johnson et al., 2013, Malloy et al., 2004)”
Quote in the paperSubstantial claim2 of 3 sources checked - Premisecitation
Astrocytes provide neurons with exogenous cholesterol in the form of apoE-containing high density lipoprotein (HDL)-like particles.
“astrocytes provide neurons with exogenous cholesterol in the form of apoE-containing high density lipoprotein (HDL)-like particles (Boyles et al., 1985, Boyles et al., 1989, Yu et al., 2010)”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Boyles et al., 1985 source
The Discussion (page unavailable) identifies apoE as an astrocyte secretory product and speculates that apoE-containing lipoproteins could redistribute lipids among nervous-system cells. It does not establish that astrocytes provide cholesterol to neurons, or that the particles involved are HDL-like. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Boyles et al., 1989 source
The Discussion (page unavailable) proposes that apoE- and apoA-I-containing lipoproteins may transfer cholesterol within an injured rat sciatic nerve, potentially to growing axons. It does not show that astrocytes provide neurons with cholesterol; it identifies macrophages as the major apoE producers in the injured nerve. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Yu et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
There was a significant effect of APOE genotype on total time spent in the open areas of the elevated zero maze.
“There was a significant effect of APOE genotype on numbers of entries into open areas (p < 0.01, ANOVA) as well as total time spent in the open areas (p < 0.001 respectively by ANOVA) of elevated zero maze (Figure 2A-B).”
Quote in the paperSubstantial claim - Findingown data
There was no difference in contextual freezing between any of the experimental groups.
“There was no difference in contextual freezing between any of the experimental groups (Figure 3E).”
Quote in the paperSubstantial claim - Findingown data
No group showed a correlation between water maze performance and apoE levels in the cortex, amygdala, or cerebellum.
“Additionally, no group showed a correlation between water maze performance and apoE levels in the cortex, amygdale or cerebellum”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, E2 and E3 demonstrated robust spatial memory retention at both 24 and 72 hours.
“When human LDLR was introduced, mice with E2 and E3 demonstrated robust spatial memory retention at both 24 and 72 hours.”
Quote in the paperSubstantial claim - Findingown data
In the elevated zero-maze, mice with E4 displayed significantly more anxiety than those with E3 or E2.
“In the elevated zero-maze, a test of anxiety-like behavior, mice with E4 displayed significantly more anxiety than those with E3 or E2.”
Quote in the paperSubstantial claim - Findingown data
In mice lacking LDLR, spatial memory retention was impaired at both 24 and 72 hours post-training, regardless of APOE genotype.
“Spatial memory retention was impaired in mice lacking LDLR when tested at both 24 and 72 hours post-training, regardless of APOE genotype.”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, E4 performed similar to E2 and E3 in the 24-hour spatial memory test.
“While mice with human LDLR and E4 performed similar to their E2 and E3 counterparts in the 24 hour spatial memory test”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, a clear pattern (E2 > E3 > E4) emerged in all brain regions measured (APOE*LDLR effect, all regions p < 0.01).
“In contrast, a clear pattern (E2 > E3 > E4) emerged in all brain regions measured in mice with human LDLR (APOE*LDLR effect, all regions p < 0.01).”
Quote in the paperSubstantial claim - Findingown data
In TR mice with endogenous mouse LDLR, plasma apoE levels were significantly elevated in human E2 compared to E3 and E4 (p<0.01).
“Similar to previously published reports (Riddell et al., 2008, Sullivan et al., 2011), we observed significantly elevated plasma apoE levels in TR mice with human E2 compared to those with E3 and E4 (p<0.01)”
Quote in the paperNot a substantial claim - Findingown data
The majority of LDLR−/− mice displayed un-directed search patterns in the second probe trial.
“In the second probe trial (P2), LDLR deficient mice failed to show a preference for the target quadrant, regardless of APOE genotype (Figure 4C) and the majority of LDLR−/− mice displayed un-directed search patterns (Figure 4G, top row).”
Quote in the paperSubstantial claim - Findingown data
When exposed to a novel object 24 hours later, all experimental groups regardless of APOE or LDLR genotype spent significantly more time examining the novel object, demonstrating robust object recognition memory.
“When exposed to a Novel object 24 hours later, all experimental groups – regardless of APOE or LDLR genotype – spent significantly more time examining the novel object, demonstrating robust object recognition memory (Figure 1B).”
Quote in the paperNot a substantial claim - Findingown data
In LDLR deficient mice, irrespective of APOE genotype, there was no positive correlation between hippocampal apoE levels and percent time spent in the target quadrant (all groups combined, r2 = 0.0065, p = 0.7502).
“This positive correlation was not present in LDLR deficient mice, irrespective of APOE genotype (all LDLR−/− groups combined, r2 = 0.0065, p = 0.7502, Pearson correlation) (Figure 7A).”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
There was a significant effect of APOE genotype on numbers of entries into open areas of the elevated zero maze.
“There was a significant effect of APOE genotype on numbers of entries into open areas (p < 0.01, ANOVA) as well as total time spent in the open areas (p < 0.001 respectively by ANOVA) of elevated zero maze (Figure 2A-B).”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, better performance in the 72-hour probe trial of the water maze was associated with higher levels of hippocampal apoE.
“In mice with human LDLR, better performance in the 72 hour probe trial of the water maze was associated with higher levels of hippocampal apoE (Figure 7B).”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
We observed a strong effect of APOE genotype on cued memory.
“Conversely, we observed a strong effect of APOE genotype on cued memory.”
Quote in the paperSubstantial claim - Findingown data
When human LDLR was present, plasma apoE concentrations were significantly higher in mice with E2 than in mice with E3 or E4.
“However, when human LDLR was present, plasma apoE concentrations were significantly higher in mice with E2 (20.3 ± 1.5 μg/ml) than E3 or E4 (7.0 ± 0.9 and 5.9 ± 0.5 μg/ml, respectively) (Figure 6B-C).”
Quote in the paperSubstantial claim - Findingown data
The interaction between E4 and LDLR resulted in deficiencies that were not present in E2 and E3, specifically in the context of long term memory retention (72 hours).
“Furthermore, the interaction between E4 and LDLR resulted in deficiencies that were not present in E2 and E3, specifically in the context of long term memory retention (72 hours).”
Quote in the paperSubstantial claim - Findingown data
Novel object recognition is unaffected by APOE and LDLR genotype.
“Novel object recognition is unaffected by APOE and LDLR genotype”
Quote in the paperNot a substantial claim - Findingown data
In TR mice with endogenous mouse LDLR, there was a significant genotype effect on apoE levels in the cortex (p < 0.05, ANOVA).
“as well as in the cortex (p < 0.05, ANOVA) (Supplemental Figure 1).”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, hippocampal apoE levels correlated with long-term spatial memory retention.
“Furthermore, in mice with human LDLR, hippocampal apoE levels correlated with long-term spatial memory retention.”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
There was a significant effect of APOE on freezing in response to the tone in the cued fear conditioning task.
“there was a significant effect of APOE (p < 0.01, repeated measures) on freezing in response to the tone.”
Quote in the paperSubstantial claim - Findingown data
ApoE levels in cortex, amygdala, or cerebellum did not correlate with other behavioral tests (object recognition, anxiety, fear conditioning, or spatial memory retention in water maze probe trials).
“nor did apoE levels in any of these brain regions correlate with other behavioral tests (object recognition, anxiety, fear conditioning, or spatial memory retention in the water maze probe trials).”
Quote in the paperSubstantial claim - Findingown data
All groups demonstrated an increase in freezing across the training session, indicating a learned fear response.
“All groups demonstrated an increase in freezing across the training session (p < 0.01, repeated measures), indicating a learned fear response (Figure 3-C-D).”
Quote in the paperNot a substantial claim - Findingown data
Anxiety-like behavior was unaffected by LDLR in this study.
“Unlike spatial memory, anxiety-like behavior was unaffected by LDLR in this study.”
Quote in the paperSubstantial claim - Findingown data
Plasma cholesterol was higher in mice with E2 compared to mice with E3, whether or not human LDLR was expressed.
“Plasma cholesterol was higher in mice with E2 compared to mice with E3, whether or not human LDLR was expressed.”
Quote in the paperNot a substantial claim - Findingown data
In human LDLR mice with E4, the correlation between hippocampal apoE levels and percent time spent in the target quadrant did not reach significance (r2 = 0.468, p = 0.089).
“While the overall trend was similar, the correlation did not reach significance in human LDLR mice with E4 (r2 = 0.468, p = 0.089, Pearson correlation).”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
In human LDLR mice, apoE levels in cortex and cerebellum were higher in E2 than in either E3 or E4.
“apoE levels in cortex and cerebellum were higher in E2 than in either E3 or E4 (Figure 6E-H, right side).”
Quote in the paperSubstantial claim - Findingown data
Introducing human LDLR in the presence of E2 or E3 completely ameliorated the spatial memory deficits observed in LDLR−/− mice.
“Importantly, introducing human LDLR in the presence of E2 or E3 completely ameliorated the spatial memory deficits observed in LDLR−/− mice.”
Quote in the paperSubstantial claim - Findingown data
Both anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype in both the absence and presence of human LDLR.
“We show that both anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype in both the absence and presence of human LDLR”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, expression of LDLR in the brain was within a physiological range comparable to that of wild type mice, ranging between 30.3 to 145.8% of wild type mice.
“In mice with human LDLR, expression of LDLR in the brain was within a physiological range comparable to that of WT mice, ranging between 30.3 to 145.8% of wild type mice (WT).”
Quote in the paperSubstantial claim - Findingown data
In most brain regions examined, APOE genotype had no effect on levels of apoE in the absence of LDLR.
“In most brain regions examined, APOE genotype had no effect on levels of apoE in the absence of LDLR.”
Quote in the paperSubstantial claim - Findingown data
There was a trend towards lower cholesterol in human LDLR mice with E4 compared to human LDLR mice with E3 or E2.
“However, there was a trend towards lower cholesterol in human LDLR mice with E4 compared to human LDLR mice with E3 or E2 .”
Quote in the paperNot a substantial claim - Findingown data
Lack of LDLR was associated with impairments in the retention of long-term spatial memory.
“Particularly, both the lack of LDLR and the specific interaction between apoE4 and the LDLR were associated with impairments in the retention of long-term spatial memory.”
Quote in the paperSubstantial claim - Findingown data
In the water maze, the absence of LDLR resulted in major deficits in spatial memory.
“In the water maze, the absence of LDLR resulted in major deficits in spatial memory.”
Quote in the paperSubstantial claim - Findingown data
Mice with E4 displayed more anxiety-like behavior than those with E3 or E2.
“Mice with E4 displayed more anxiety-like behavior than those with E3 or E2.”
Quote in the paperSubstantial claim - Findingown data
In human LDLR mice with all three apoE isoforms analyzed together, there was a strong positive correlation between hippocampal apoE levels and percent time spent in the target quadrant (r2 = 0.722, p < 0.001).
“When the data of human LDLR mice with all three apoE isoforms were analyzed together, there was a strong positive correlation between hippocampal apoE levels and the percent time spent in the target quadrant (r2 = 0.722, p < 0.001, Pearson correlation).”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
In human LDLR mice, apoE levels in the hippocampus and amygdala were higher in E2 than E4 mice.
“In human LDLR mice, apoE levels in the hippocampus and amygdala were higher in E2 than E4 mice”
Quote in the paperSubstantial claim - Findingown data
In the cerebellum of LDLR−/− mice, levels of apoE were significantly greater in E2 than E3 or E4 mice.
“However, in the cerebellum of LDLR−/− mice, levels of apoE were significantly greater in E2 than E3 or E4 mice (Figure 6D-H, left side).”
Quote in the paperSubstantial claim - Findingown data
Fasting plasma cholesterol concentrations were drastically altered by both APOE and LDLR genotype.
“Fasting plasma cholesterol concentrations were drastically altered by both APOE and LDLR genotype (APOE effect p < 0.001, LDLR effect p < 0.001, APOE × LDLR interaction, p < 0.001, ANOVA).”
Quote in the paperNot a substantial claim - Findingown data
In human LDLR mice with E2, hippocampal apoE levels were positively correlated with percent time spent in the target quadrant in the probe trial (r2 = 0.695, p < 0.05).
“Hippocampal apoE levels were positively correlated with the percent time spent in the target quadrant in the probe trial in human LDLR mice with E2 (r2 = 0.695, p < 0.05, Pearson correlation)”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
There were no group differences in ability to reach the platform during the visible platform sessions.
“There were no group differences in ability to reach the platform during the visible platform sessions (Figure 4A-B, “Visible”).”
Quote in the paperSubstantial claim - Findingown data
In mice with human LDLR, E4 showed impaired long-term memory retention during the 72-hour test.
“they showed impaired long term memory retention during the 72 hour test.”
Quote in the paperSubstantial claim - Findingown data
In human LDLR mice with E3, hippocampal apoE levels were positively correlated with percent time spent in the target quadrant in the probe trial (r2 = 0.695, p < 0.05 and r2 = 0.884, p < 0.01).
“and E3 (r2 = 0.695, p < 0.05 and r2 = 0.884, p < 0.01, Pearson correlation).”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
- Findingown data
In TR mice with endogenous mouse LDLR, there was a significant genotype effect on apoE levels when all brain regions were analyzed together (p<0.01, repeated measures).
“as well as a significant genotype effect on apoE levels when all regions were analyzed together (p<0.01, Repeated Measures)”
Quote in the paperSubstantial claim - Findingown data
In the absence of LDLR, plasma apoE concentrations did not differ by APOE genotype.
“In the absence of LDLR, plasma apoE concentrations did not differ by APOE genotype (Figure 6B, left).”
Quote in the paperSubstantial claim - Findingown data
Cholesterol levels in the cortex did not significantly differ by APOE genotype.
“Cholesterol levels in the cortex did not significantly differ by APOE genotype.”
Quote in the paperNot a substantial claim - Findingown data
In both the absence and presence of human LDLR, mice with E4 spent less time in the open area of the zero maze compared to mice with E3 or E2.
“In both the absence and presence of human LDLR, mice with E4 spent less time in the open area of the zero maze (13.0 ± 3.6, 14.3 ± 4.2%) compared to mice with E3 (18.6 ± 6.0, 19.4 ± 6.1 %) or E2 (24.5 ± 4.5, 26.3 ± 8.9 %) (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
Performance improved during the visible and hidden platform sessions.
“Performance improved during the visible and hidden platform sessions (Session effect in each, p < 0.01).”
Quote in the paperNot a substantial claim - Findingown data
In LDLR deficient mice, apoE levels in the cortex, hippocampus and amygdala were similar among E2, E3, and E4.
“LDLR deficient mice with E2, E3 or E4 had similar levels of apoE in the cortex, hippocampus and amygdala (Figure 6E-G, left side).”
Quote in the paperSubstantial claim - Findingown data
Anxiety was strongly determined by APOE genotype in both the presence and absence of LDLR.
“Instead, anxiety was strongly determined by APOE genotype in both the presence and absence of LDLR.”
Quote in the paperSubstantial claim - Findingown data
Human LDLR expression considerably lowered total plasma cholesterol regardless of apoE isoforms.
“Human LDLR expression considerably lowered total plasma cholesterol regardless of apoE isoforms (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
The effect of LDLR absence on spatial memory is independent of APOE genotype.
“Here we extend these findings to show that this effect is independent of APOE genotype.”
Quote in the paperNot a substantial claim - Findingown data
In LDLR−/− mice, the freezing response to the tone was apoE isoform-dependent (E4 > E3 > E2).
“In LDLR−/− mice, the freezing response to the tone was apoE isoform-dependent (E4 > E3 > E2).”
Quote in the paperSubstantial claim - Findingown data
In the 72-hour probe trial, mice lacking the LDLR failed to show a preference for the target quadrant, regardless of APOE genotype.
“As in the first two probe trials, mice lacking the LDLR failed to show a preference for the target quadrant, regardless of APOE genotype (Figure 4E, G bottom row).”
Quote in the paperSubstantial claim - Findingown data
All groups spent a comparable amount of time exploring each of the two identical objects on the first day of the novel object recognition paradigm.
“All groups spent a comparable amount of time exploring each of the two identical objects (Figure 1A).”
Quote in the paperSubstantial claim - Findingown data
None of the groups showed spatial memory retention in the first probe trial.
“None of the groups showed spatial memory retention in the first probe trial (not shown).”
Quote in the paperNot a substantial claim - Findingown data
Following additional training, some groups did show spatial memory retention.
“However, following additional training, some groups did show spatial memory retention.”
Quote in the paperNot a substantial claim - Findingown data
Hippocampal cholesterol was not affected by APOE genotype.
“Hippocampal cholesterol was not affected by APOE genotype (Figure 5, shaded bars).”
Quote in the paperNot a substantial claim - Findingown data
In the second probe trial (P2), LDLR deficient mice failed to show a preference for the target quadrant, regardless of APOE genotype.
“In the second probe trial (P2), LDLR deficient mice failed to show a preference for the target quadrant, regardless of APOE genotype (Figure 4C) and the majority of LDLR−/− mice displayed un-directed search patterns (Figure 4G, top row).”
Quote in the paperSubstantial claim - Findingown data
Levels of hippocampal apoE correlate with long term spatial memory retention in mice with human LDLR.
“Finally, levels of hippocampal apoE correlate with long term spatial memory retention in mice with human LDLR.”
Quote in the paperSubstantial claim - Findingown data
There was no significant difference in human LDLR expression between E2, E3 and E4 mice.
“There was no significant difference in human LDLR expression between E2, E3 and E4 mice (88.5 ± 17.2, 92.1 ± 10.7, and 87.3 ± 19.6 % of WT, respectively) (Figure 6A).”
Quote in the paperSubstantial claim - Findingown data
Neither cortical nor hippocampal cholesterol levels were significantly affected by APOE genotype in human apoE mice with human LDLR.
“Neither cortical nor hippocampal cholesterol levels o were significantly affected by APOE genotype, although there was a trend towards lower cortical cholesterol in human LDLR mice with E4.”
Quote in the paperSubstantial claim - Findingown data
There was a trend towards lower cortical cholesterol in human LDLR mice with E4.
“although there was a trend towards lower cortical cholesterol in human LDLR mice with E4”
Quote in the paperNot a substantial claim - Findingown data
Brain cholesterol concentrations did not correlate with any of the behavioral outcomes measured in this study.
“However, brain cholesterol concentrations did not correlate with any of the behavioral outcomes measured in this study.”
Quote in the paperNot a substantial claim - Findingnone given
ApoE levels in E2 mice with human LDLR did not differ in any brain region from apoE levels in any of the LDLR−/− mice.
“Interestingly, apoE levels in E2 mice with human LDLR did not differ in any brain region from apoE levels in any of the LDLR−/− mice.”
Quote in the paperSubstantial claim- Rests on an assumption: The insoluble (detergent-soluble) fraction more accurately reflects the levels of lipidated apoE.
- Findingnone given
ApoE levels in E4 mice with human LDLR were significantly lower than those of all LDLR−/− mice in the four brain regions analyzed.
“Conversely, apoE levels in E4 mice with human LDLR were significantly lower than those of all LDLR−/− mice in the four brain regions analyzed.”
Quote in the paperSubstantial claim- Rests on an assumption: The insoluble (detergent-soluble) fraction more accurately reflects the levels of lipidated apoE.
- Premisecitation
A functional interaction between apoE and LDLR determines Alzheimer's disease risk.
“Furthermore, the risk associated with a certain LDLR polymorphism differs dramatically depending on the patients’ APOE genotype, implying that a functional interaction between apoE and LDLR determines AD risk (Cheng et al., 2004, Retz et al., 2001).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cheng et al., 2004
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Retz et al., 2001 source
- Premisecitation
In patients who lack functioning LDLR, the disparities in cardiovascular disease risk usually associated with APOE genotype disappear.
“For example, the disparities in CVD risk usually associated with APOE genotype disappear in patients who lack functioning LDLR, suggesting that the diseases-modifying effects of the apoE isoforms depend on the presence of a fully functioning LDLR protein (Vermissen et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vermissen et al., 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductown data
There were no apparent differences in health or physical appearance among the experimental groups.
“There were also no apparent differences in health or physical appearance, and all groups performed similarly with regard to activity levels in an open field, sensorimotor function on a Rotarod, and swim speeds in the water maze (Table 2).”
Quote in the paperNot a substantial claim - Premisecitation
The risk associated with a certain LDLR polymorphism differs dramatically depending on the patients' APOE genotype.
“Furthermore, the risk associated with a certain LDLR polymorphism differs dramatically depending on the patients’ APOE genotype, implying that a functional interaction between apoE and LDLR determines AD risk (Cheng et al., 2004, Retz et al., 2001).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cheng et al., 2004
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Retz et al., 2001 source
- Premisecitation
The disease-modifying effects of the apoE isoforms depend on the presence of a fully functioning LDLR protein.
“For example, the disparities in CVD risk usually associated with APOE genotype disappear in patients who lack functioning LDLR, suggesting that the diseases-modifying effects of the apoE isoforms depend on the presence of a fully functioning LDLR protein (Vermissen et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vermissen et al., 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The interaction between LDLR and E4 appears to be an important disease modifying mechanism in the setting of CVD.
“but regardless of the mechanism, the interaction between LDLR and E4 appears to be an important disease modifying mechanism in the setting of CVD.”
Quote in the paperSubstantial claim - Study design and conductown data
There were no group differences in swim speeds in the water maze.
“There were no group differences in swim speeds (Table 2).”
Quote in the paperSubstantial claim - Study design and conductown data
There were no group differences in the response to the shock during fear conditioning training.
“There were no group differences in the response to the shock (Figure 3B).”
Quote in the paperNot a substantial claim - Premisecitation
In mice, the introduction of human LDLR results in apoE isoform-dependent differences in diet-induced atherosclerotic plaque development.
“In mice, the introduction of human LDLR results in apoE isoform-dependent differences in diet-induced atherosclerotic plaque development (Malloy et al., 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Malloy et al., 2004 source
- Interpretationown data
The apoE isoforms differentially affect anxiety-like behavior (E4 > E3 ≥ E2) through an LDLR-independent process.
“This data suggests that the apoE isoforms differentially affect anxiety-like behavior (E4 > E3 ≥ E2) through an LDLR-independent process.”
Quote in the paperSubstantial claim - Premisecitation
The increased CVD risk normally associated with APOE4 genotype disappears in Familial Hypercholesterolemia patients who lack functioning LDLR.
“Interestingly, the increased CVD risk normally associated with APOE4 genotype disappears in Familial Hypercholesterolemia (FH) patients, who lack functioning LDLR (Vermissen et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vermissen et al., 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The LDLR is the only receptor in its class to show varying binding affinities for the three apoE isoforms (E4 > E3 >> E2).
“While numerous lipoprotein receptors have been shown to interact with apoE in the brain, the LDLR is the only receptor in its class of receptors to show varying binding affinities for the three apoE isoforms (E4 > E3 >> E2) (Innerarity et al., 1983, Yamamoto et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
The pathways that underlie spatial memory require functional interaction between apoE and the LDLR.
“These data suggest that the pathways that underlie spatial memory - at least in regards to specific cognitive processes tested by the water maze – require functional interaction between apoE and the LDLR.”
Quote in the paperSubstantial claim - Interpretationcitation
A functional interaction between apoE and LDLR may modify AD risk in an apoE isoform-dependent manner.
“These studies imply that a functional interaction between apoE and LDLR may modify AD risk in an apoE isoform-dependent manner.”
Quote in the paperSubstantial claim - Interpretationown data
The strong APOE genotype effect on anxiety (E4 > E3 > E2) occurs through an LDLR-independent mechanism.
“These data suggest that this strong APOE genotype effect on anxiety (E4 > E3 > E2) occurs through an LDLR-independent mechanism.”
Quote in the paperSubstantial claim - Interpretationreasoning
The partial rescue of long-term spatial memory deficits by human LDLR in E4 mice may be due to an inability of the LDLR to rescue these impairments by interacting with E4 as it does with E2 and E3.
“This may be due to an inability of the LDLR to rescue the impairments in long-term spatial memory by interacting with E4 as it is able to do with E2 and E3.”
Quote in the paperSubstantial claim - Interpretationcitation
Upregulation of LDLR in the brain is a potential therapeutic strategy for AD.
“These studies, in which LDLR over-expression increases Aβ clearance, point to upregulation of LDLR in the brain as a potential therapeutic strategy for AD.”
Quote in the paperSubstantial claim - Interpretationown data
Regional variations in apoE level may exist.
“Together, these data suggest that the LDLR regulates brain apoE levels in an isoform-dependent manner, and that regional variations in apoE level may also exist.”
Quote in the paperNot a substantial claim - Interpretationown data
The specific interaction between apoE4 and the LDLR was associated with impairments in the retention of long-term spatial memory.
“Particularly, both the lack of LDLR and the specific interaction between apoE4 and the LDLR were associated with impairments in the retention of long-term spatial memory.”
Quote in the paperSubstantial claim - Interpretationreasoning
The apoE isoforms may exert unique effects in the amygdala through an LDLR-independent mechanism.
“these data imply that the apoE isoforms may exert unique effects in this particular brain region through an LDLR-independent mechanism.”
Quote in the paperSubstantial claim- Rests on an assumption: Both contextual fear conditioning and cued fear conditioning strongly rely on the amygdala.
- Premisecitation
A SNP in LDLR exon 12 was associated with increased AD risk in men.
“Zou et al. (2008) demonstrated that a SNP in LDLR exon 12 was associated with increased AD risk in men.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zou et al. (2008) source
- Interpretationreasoning
The apoE isoform present is more important than actual apoE levels in the amygdala.
“more likely that – at least in regard to the amygdale – the apoE isoform present is more important than actual apoE levels.”
Quote in the paperSubstantial claim - Premisecitation
Type III Hyperlipoproteinemia and grossly elevated plasma apoE concentrations in TR mice (and knock-in mice) with E2 are significant confounders.
“the type III Hyperlipoproteinemia (HLP) and grossly elevated plasma apoE concentrations in TR mice (and knock-in mice) with E2 are significant confounders (Mahley et al., 1999)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mahley et al., 1999 source
- Interpretationown data
The LDLR regulates brain apoE levels in an isoform-dependent manner.
“Together, these data suggest that the LDLR regulates brain apoE levels in an isoform-dependent manner, and that regional variations in apoE level may also exist.”
Quote in the paperSubstantial claim - Interpretationown data
LDLR regulates hippocampus apoE levels in an isoform dependent manner.
“Taken together, these data suggest that: 1) LDLR regulates hippocampus apoE levels in an isoform dependent manner”
Quote in the paperSubstantial claim- Rests on an assumption: Trafficking of apoE-containing HDL-like particles in the brain is likely affected by interaction of apoE with the LDLR, as it is in the periphery.
- Interpretationown data
This is the first study to demonstrate an association between hippocampus human apoE levels and cognitive performance in a test of long term spatial memory.
“To our knowledge, this is the first study to demonstrate an association between hippocampus human apoE levels and cognitive performance in a test of long term spatial memory.”
Quote in the paperSubstantial claim - Interpretationown data
In regards to the retention of long term spatial memory, total apoE levels may be more important than the specific isoform present.
“2) in regards to the retention of long term spatial memory, total apoE levels may be more important than the specific isoform present.”
Quote in the paperSubstantial claim - Study design and conductnone given
Expression of human LDLR in hemizygous human LDLR (h/−) mice is limited to a range of 16-205%, with a mean of 99%, compared to murine LDLR in wild-type mice.
“Expression of human LDLR in these mice is limited to a range of 16-205%, with a mean of 99%, compared to murine LDLR in wild-type mice.”
Quote in the paperNot a substantial claim
- Probably not a substantial claim. 35
- It may state two separate claims as one. 40
- The quote only partly states this claim. 2
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationFreezing is a widely used indicator of conditioned fear.
“Freezing, defined as somatomotor immobility with the exception of respiration, is considered a post-exposure fear response, and is a widely used indicator of conditioned fear (Maren 2001).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Maren 2001 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe Morris water maze is a well-established test to identify spatial learning and/or memory deficits.
“The Morris water maze is a well-established test to identify spatial learning and/or memory deficits and has been employed in numerous studies of mouse models of neurological disease (Vorhees and Williams, 2006).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Vorhees and Williams, 2006 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAPOE genotype modulates anxiety and anxiety-like behavior in humans and in mice.
“APOE genotype has been shown to modulate anxiety and anxiety-like behavior in humans and in mice (Raber et al., 2007).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Raber et al., 2007 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSeveral vascular risk factors, including the apoE-LDLR system, are shared by AD and CVD.
“In addition, several vascular risk factors, including apoE-LDLR system, are shared by AD and CVD (Altman et al., 2010).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Altman et al., 2010 source
The Conclusions report overlapping risk factors for AD and atherosclerotic cardiovascular disease, including dyslipidaemia and the apoE4 allele. The APOE STRUCTURE AND FUNCTION section says apoE interacts with LDL receptors, but does not identify the apoE–LDLR system as a shared risk factor; that specific example goes beyond what the paper states. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAPOE genotype has been shown to affect fear conditioning in mice.
“APOE genotype has been shown to affect fear conditioning in mice (Kornecook et al., 2010, Olsen et al., 2012).”
Quote in the paperNot a substantial claim2 of 2 sources checkedIt may state two separate claims as one.
PremisecitationWhen murine LDLR is replaced with human LDLR, plasma lipids return to normal physiological levels, allowing for study of the ε2 allele in a physiologically relevant context.
“When murine LDLR is replaced with human LDLR, as in this study and others (Knouff et al. 2001), this issue is resolved as plasma lipids return to normal physiological levels, allowing for study of the ε2 allele in a physiologically relevant context.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Knouff et al. 2001 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationVascular brain injury may predict cognitive outcome better than amyloid β deposition.
“Vascular brain injury may predict cognitive outcome better than amyloid β deposition (Marchant et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Marchant et al., 2013 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationLDLR over-expression in the brain increased the rate of brain-to-blood clearance of both exogenously administered and endogenous Aβ.
“further work from the same laboratory showed that LDLR over-expression in the brain increased the rate of brain-to-blood clearance of both exogenously administered and endogenous Aβ (Castellano et al., 2012)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Castellano et al., 2012 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationIn another AD mouse model, LDLR deficiency had no effect on brain Aβ levels.
“in another study LDLR deficiency had no effect on brain Aβ levels (Fryer et al., 2005)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Fryer et al., 2005 source
The Discussion and the section on Aβ ratios in young APPsw mice report comparisons among mice expressing murine apoE, human apoE3, and human apoE4, not mice with LDLR deficiency. Searches for LDLR deficiency and low-density lipoprotein receptor knockout found no passage reporting its effect on brain Aβ levels; the reference to LDL receptor-related protein-1 is not such a result. The indexed passages provide no page numbers. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationReducing apoE levels using Cre-mediated gene excision resulted in lower brain Aβ levels.
“Similarly, reducing apoE levels using Cre-mediated gene excision resulted in lower brain Aβ levels (Bien-Ly et al., 2012).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bien-Ly et al., 2012 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationIn soluble preparations of human synaptosomes, levels of apoE/Aβ complex were lower in AD patients compared to controls, as well as lower in E4+ compared to E4- patients with AD.
“Tai et al. (2013) recently showed that in soluble preparations of human synaptosomes, levels of apoE/Aβ complex were lower in AD patients compared to controls, as well as lower in E4+ compared to E4- patients with AD.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Tai et al. (2013) source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationLower brain apoE levels in hemizygous human apoE mice were associated with decreased amyloid deposition.
“Kim et al. (2011) demonstrated that lower brain apoE levels in hemizygous human apoE mice were associated with decreased amyloid deposition.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Kim et al. (2011) source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationIncreasing the levels and lipidation of apoE is a therapeutic mechanism attributed to the class of peroxisome proliferator-activated receptor-γ, retinoid × receptor, and liver × receptor agonists.
“In fact, increasing the levels and lipidation of apoE is a therapeutic mechanism attributed to the class of peroxisome proliferator-activated receptor-γ, retinoid × receptor, and liver × receptor agonists that have shown recent promise (Cao et al., 2007, Cramer et al., 2012, Lefterov et al., 2007, Terwel et al., 2011).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites Cao et al., 2007 source
- cites Cramer et al., 2012 source
- cites Lefterov et al., 2007 source
The Discussion reports increased apoE protein after LXR agonist treatment and proposes that LXR-driven apoE and ABCA1 expression yields more properly lipidated brain apoE. It presents the therapeutic mechanism as a hypothesis in APP23 mice; it does not establish the same mechanism for peroxisome proliferator-activated receptor-γ or retinoid X receptor agonists. (LLM, conf=0.86)
Experimental — accuracy not yet measured
It may state two separate claims as one.
PremisecitationOver-expression of LDLR, while increasing clearance of Aβ, results in decreased brain apoE concentrations.
“Furthermore, over-expression of LDLR – while increasing clearance of Aβ – results in decreased brain apoE concentrations (Kim et al., 2009), although this clearance may occur through an apoE-independent pathway (Basak et al., 2012).”
Quote in the paperNot a substantial claim1 of 2 sources checkedIt may state two separate claims as one.
Findingown dataCued fear conditioning showed an APOE effect (E4 > E3 > E2) that was similar in the presence and absence of human LDLR.
“Similar to anxiety-like behavior in the elevated zero maze, cued fear conditioning showed an APOE effect (E4 > E3 > E2) that was similar in the presence and absence of human LDLR.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataBoth the lack of LDLR and the interaction between E4 and the LDLR were associated with significant impairments in the retention of long term spatial memory.
“Both the lack of LDLR and the interaction between E4 and the LDLR were associated with significant impairments in the retention of long term spatial memory.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn the presence of human LDLR, mice with E3 or E4 had a similar freezing response to the tone, while mice with E2 had significantly lower freezing levels compared to mice with E4, and there was a trend towards lower freezing levels than in mice with E3.
“In the presence of human LDLR, mice with E3 or E4 had a similar freezing response to the tone, while mice with E2 had significantly lower freezing levels (p < 0.05, repeated measures) compared to mice with E4, and there was a trend towards lower freezing levels than in mice with E3 (p = 0.084) (Figure 3G).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataThere was no effect of APOE, LDLR or APOE*LDLR interaction for contextual fear conditioning, but a strong effect of APOE for cued fear conditioning (E4 > E3 > E2) that was independent of LDLR status.
“In summary, there was no effect of APOE, LDLR or APOE*LDLR interaction for contextual fear conditioning, but a strong effect of APOE for cued fear conditioning (E4 > E3 > E2) that was independent of LDLR status.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataLDLR did not alter the cued fear conditioning response and there was no APOE × LDLR interaction.
“While LDLR did not alter the cued fear conditioning response and there was no APOE × LDLR interaction, there was a significant effect of APOE (p < 0.01, repeated measures) on freezing in response to the tone.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataPlasma apoE levels were modulated by APOE genotype as well as markedly lowered by LDLR expression.
“Plasma apoE levels were modulated by APOE genotype as well as markedly lowered by LDLR expression (LDLR effect p < 0.001, APOE effect p < 0.01 by ANOVA).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn the presence of E4, introducing human LDLR only partially ameliorated these deficits; E4 mice with human LDLR demonstrated memory retention at 24 hours, but not 72 hours, post-training.
“However, in the presence of E4, introducing human LDLR only partially ameliorated these deficits; E4 mice with human LDLR demonstrated memory retention at 24 hours, but not 72 hours, post-training.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataIn this study, we did not observe differences in body weight or adipose tissue mass based on apoE isoform or the presence of LDLR.
“In this study, we did not observe differences in body weight or adipose tissue mass based on apoE isoform or the presence of LDLR.”
Quote in the paperNot a substantial claimIt may state two separate claims as one. The quote only partly states this claim.
Findingown dataBrain apoE levels are regulated by APOE*LDLR interaction and decreased in mice with apoE4 and human LDLR.
“Brain apoE levels are regulated by APOE*LDLR interaction; decreased in mice with apoE4 and human LDLR”
Quote in the paperSubstantial claim- Rests on an assumption: LDLR has a high affinity for apoE and is the only member of its receptor family to demonstrate an apoE isoform-specific binding affinity (E4>E3>>E2).
It may state two separate claims as one.
Findingown dataE4 mice with human LDLR did not spend significantly more time in the target quadrant than the right and opposite quadrants, suggesting deficiencies in spatial memory.
“In contrast, E4 mice with human LDLR did not spend significantly more time in the target quadrant than the right and opposite quadrants, suggesting deficiencies in spatial memory.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn this study, we did not observe an effect of APOE, LDLR or an APOE × LDLR interaction for contextual fear conditioning.
“In this study, we did not observe an effect of APOE, LDLR or an APOE × LDLR interaction for contextual fear conditioning.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataThe presence of human LDLR resulted in significant preference for the target quadrant and clear search strategies in E2, E3 and E4 mice.
“However, the presence of human LDLR resulted in significant preference for the target quadrant and clear search strategies in E2, E3 and E4 mice (47.0 ± 25.8, 41.5 ± 12.2, and 50.0 ± 21.6 % time in target quadrant, respectively) (Figure 4D, H top row).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataLDLR−/− mice with E4 had a significantly higher freezing response compared to mice with E3 or E2, while mice with E3 tended to freeze more than mice with E2.
“LDLR−/− mice with E4 had a significantly higher freezing response compared to mice with E3 (p < 0.05) or E2 (p < 0.01), while mice with E3 tended to freeze more than mice with E2 (p = 0.063) (Figure 3F).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn the brain, when all regions were analyzed together, there was a significant effect of APOE, LDLR, and a significant APOE × LDLR interaction (p < 0.01, repeated measures).
“In the brain, there was a significant effect of APOE, LDLR and a significant APOE × LDLR interaction when all regions were analyzed together (p < 0.01, repeated measures).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataE2 and E3 mice with human LDLR showed a clear preference for the target quadrant and accurate, focused search strategies.
“Conversely, E2 and E3 mice with human LDLR showed a clear preference for the target quadrant (42.4 ± 18.1 and 40.7 ± 12.5 % time in target quadrant, respectively) (Figure 4F), and accurate, focused search strategies (Figure 4H, bottom row, shows representative trials).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataWhile plasma cholesterol tended to be lower in E4 mice compared to E3 mice when there was no LDLR, introduction of the human LDLR resulted in significantly higher plasma cholesterol in E4 mice compared to E3 mice.
“However, while plasma cholesterol tended to be lower in E4 mice compared to E3 mice when there was no LDLR, introduction of the human LDLR resulted in significantly higher plasma cholesterol in E4 mice compared to E3 mice (Table 1).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataFreezing response during training was not affected by APOE or LDLR and there was no APOE × LDLR interaction, although there was a trend towards higher freezing in mice with E4.
“Freezing response during training was not affected by APOE or LDLR and there was no APOE × LDLR interaction, although there was a trend towards higher freezing in mice with E4 (APOE effect p = 0.079, repeated measures).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
FindingreasoningBoth the lack of LDLR and the specific interaction between E4 and the LDLR were associated with impairments in the retention of long term spatial memory.
“Interestingly, both the lack of LDLR and the specific interaction between E4 and the LDLR were associated with impairments in the retention of long term spatial memory.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataHippocampus apoE levels are strongly positively correlated with long-term spatial memory retention (water maze performance) in mice with human LDLR.
“We observed a strong positive correlation between hippocampus apoE levels and performance in the water maze.”
- Also stated in: § Discussion · plain
“Importantly, this correlation was only observed in mice with human LDLR.”
- Also stated in: § Discussion · plain
“Finally, levels of hippocampus apoE correlate with long term spatial memory retention in mice with human LDLR.”
Quote in the paperSubstantial claim- Rests on an assumption: The insoluble (detergent-soluble) fraction more accurately reflects the levels of lipidated apoE.
- Also stated in: § Discussion · plain
It may state two separate claims as one.
PremisecitationIn mice, introduction of human LDLR results in higher plasma cholesterol and increased cardiovascular complications in the presence of E4.
“In mice, introduction of human LDLR results in higher plasma cholesterol and increased cardiovascular complications in the presence of E4 (Altenburg et al., 2007, Malloy et al., 2004, Johnson et al., 2013).”
Quote in the paperSubstantial claim0 of 3 sources checkedIt may state two separate claims as one.
Study design and conductown dataAll groups performed similarly with regard to activity levels in an open field, sensorimotor function on a Rotarod, and swim speeds in the water maze.
“There were also no apparent differences in health or physical appearance, and all groups performed similarly with regard to activity levels in an open field, sensorimotor function on a Rotarod, and swim speeds in the water maze (Table 2).”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe novel object recognition task is based on rodents' natural curiosity and propensity to orient their head toward a novel stimulus.
“The Novel object recognition task is based on rodents’ natural curiosity and propensity to orient their head toward a novel stimulus (Honey et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Honey et al., 1998 source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAPOE ε4 is a major genetic risk factor for cardiovascular disease and Alzheimer's disease.
“APOE ε4 (E4) is a major genetic risk factor for cardiovascular disease (CVD) and Alzheimer's disease (AD).”
- Also stated in: § Introduction · plain
“For instance, E4 is associated with an increased risk of CVD (Mahley and Rall, 2000) and AD (Raber et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked- Also stated in: § Introduction · plain
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe elevated zero maze is a canonical test of anxiety-like behavior.
“we used the elevated zero maze, a canonical test of anxiety-like behavior (Shepard et al., 1994).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shepard et al., 1994
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe apoE-LDLR interaction appears critical in both cardiovascular disease and Alzheimer's disease.
“The apoE-LDLR interaction appears critical in both CVD and AD.”
- Also stated in: § Abstract · hedged
“Evidence suggests that a functional interaction between apoE and LDLR influences the risk of CVD and AD.”
Quote in the paperSubstantial claim0 of 3 sources checked- Also stated in: § Abstract · hedged
It may state two separate claims as one.
Study design and conductown dataNo significant differences were observed in body weight, adipose tissue, liver, or brain weight among the experimental groups.
“No significant differences were observed in body weight, or in adipose tissue, liver, or brain weight (Table 1).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationIn mice, the effect of human LDLR introduction on plasma cholesterol and cardiovascular complications does not occur with E3, and with E2 it lowers cholesterol and improves cardiovascular outcomes.
“This effect does not occur in mice expressing E3, and in the presence of E2 actually lowers cholesterol and improves cardiovascular outcomes (Knouff et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Knouff et al., 2001 source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationLDLR over-expression reduced brain apoE levels and reduced amyloid β aggregation.
“Kim et al. (2009) showed that LDLR over-expression reduced brain apoE levels and reduced amyloid β aggregation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kim et al. (2009) source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Interpretationown dataThese data do not rule out potential effects of APOE genotype on adipose tissue function, particularly in the context of metabolic challenges such as obesity or diabetes.
“However, these data do not rule out potential effects of APOE genotype on adipose tissue function, particularly in the context of metabolic challenges such as obesity or diabetes.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataCued associative memory and anxiety-like behavior were influenced by APOE genotype in an LDLR-independent manner, while spatial memory was heavily influenced by LDLR expression as well as by an APOE × LDLR interaction.
“While cued associative memory and anxiety-like behavior were influenced by APOE genotype in an LDLR-independent manner, spatial memory was heavily influenced by LDLR expression as well as by an APOE × LDLR interaction.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataPlasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform-dependent interactions between apoE and LDLR.
“Our results show that plasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform-dependent interactions between apoE and LDLR.”
Quote in the paperSubstantial claim- Rests on an assumption: LDLR has a high affinity for apoE and is the only member of its receptor family to demonstrate an apoE isoform-specific binding affinity (E4>E3>>E2).
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAnxiety is inversely related to cognitive function, particularly in E4 homozygotes.
“anxiety is inversely related to cognitive function (Porter et al., 2003), particularly in E4 homozygotes (Stonnington et al., 2011)”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationIn cell culture, overexpression of APP led to increased expression of LDLR and altered receptor localization.
“In cell culture, overexpression of APP led to increased expression of LDLR and altered receptor localization (Abisambra et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abisambra et al., 2010 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationIn one AD mouse model, amyloid deposition was enhanced on a LDLR null background.
“one study showing that amyloid deposition was enhanced on a LDLR null background (Katsouri et al., 2011)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Katsouri et al., 2011 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationContextual fear conditioning involves complex polymodal processing and is hippocampus and amygdala-dependent, while fear conditioning to a modality-specific cue is hippocampus-independent.
“Contextual fear conditioning is considered to involve complex polymodal processing, and to be hippocampus and amygdala-dependent, while fear conditioning to a modality-specific cue (e.g. a tone) is considered to be hippocampus-independent (Debiec et al., 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Debiec et al., 2004 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAnxiety symptoms occur in 50-75% of AD patients.
“Anxiety symptoms occur in 50-75% of AD patients (Gustavson et al., 2004)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gustavson et al., 2004 source
It may state two separate claims as one.
Interpretationown dataAnxiety-like behavior and cued associative memory occur via an LDLR independent mechanism.
“suggesting that these processes occur via an LDLR independent mechanism.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataThe interaction between apoE and LDLR appears especially important in the regulation of plasma and brain apoE levels and spatial memory retention in the water maze.
“Conversely, the interaction between apoE and LDLR appears especially important in the regulation of plasma and brain apoE levels and spatial memory retention in the water maze.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataThere were no genotype differences in cued task learning or spatial learning.
“These data indicate that there were no genotype differences in cued task learning or spatial learning.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataBoth anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype, but these processes appear to occur via an LDLR-independent mechanism.
“Conversely, both anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype, but these processes appear to occur via an LDLR-independent mechanism.”
- Also stated in: § Discussion · hedged
“In summary, both anxiety-like behavior and cued associative memory are strongly influenced by APOE genotype, but these processes appear to occur via an LDLR-independent mechanism.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · hedged
It may state two separate claims as one.
Interpretationown dataThe LDLR plays a role in regulating hippocampal apoE levels and long-term retention of spatial memory.
“These data suggest a role for the LDLR in regulating hippocampal apoE levels and long-term retention of spatial memory.”
Quote in the paperSubstantial claim- Rests on an assumption: The hippocampus is a brain region critical for performance on the water maze spatial memory task.
It may state two separate claims as one.
Interpretationown dataThe apoE-LDLR interaction affects regional brain apoE levels, brain cholesterol, and cognitive function in an apoE isoform-dependent manner.
“In summary, we demonstrate that the apoE-LDLR interaction affects regional brain apoE levels, brain cholesterol, and cognitive function in an apoE isoform-dependent manner.”
Quote in the paperSubstantial claim- Rests on an assumption: LDLR has a high affinity for apoE and is the only member of its receptor family to demonstrate an apoE isoform-specific binding affinity (E4>E3>>E2).
Probably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationreasoningThese memory deficits may arise through a biological mechanism that is unique to the E4-LDLR interaction.
“Conversely, these memory deficits may arise through a biological mechanism that is unique to the E4-LDLR interaction.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationA specific LDLR haplotype was associated with reduced AD risk.
“Gopalraj et al. (2005) showed that a specific LDLR haplotype was associated with reduced AD risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gopalraj et al. (2005) source
It may state two separate claims as one.
Interpretationown dataBoth the absence of LDLR (regardless of apoE isoform) and the specific combination of E4 and human LDLR result in deficits in long-term spatial memory.
“Taken together, both the absence of LDLR (regardless of apoE isoform), as well as the specific combination of E4 and human LDLR, result in deficits in long-term spatial memory.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAnxiety is more profound in ε4 than ε3 homozygote men with probable AD.
“is more profound in ε4 than ε3 homozygote men with probable AD (Robertson et al., 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Robertson et al., 2005 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationreasoningThe apoE-LDLR interaction may play an indirect role in the context of AD, such as through regulation of vascular function.
“The apoE-LDLR interaction may play an indirect role in the context of AD, such as through regulation of vascular function.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationThe lipidation status of apoE directly affects its structure and function, including its interaction with amyloid β.
“The lipidation status of apoE directly affects its structure and function (Hauser et al., 2011), including its interaction with amyloid β (Fan et al., 2009, LaDu et al., 1994, Tokuda et al., 2000).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationOther studies show severe learning and memory deficits in apoE deficient mice.
“while others show severe learning and memory deficits (Gordon et al., 1995, Oitzl et al., 1997, Veinbergs et al., 1999)”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationIt remains unclear exactly how apoE levels are altered during normal and pathological aging.
“Still, it remains unclear exactly how apoE levels are altered during normal and pathological aging, and if alterations in concentrations of brain apoE could affect pathways of learning and memory that rely on apoE-mediated lipid trafficking or signaling (Yu et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yu et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataPlasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform specific interactions between apoE and LDLR.
“Conversely, plasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform specific interactions between apoE and LDLR.”
Quote in the paperSubstantial claim- Rests on an assumption: Trafficking of apoE-containing HDL-like particles in the brain is likely affected by interaction of apoE with the LDLR, as it is in the periphery.
- Rests on an assumption: The insoluble (detergent-soluble) fraction more accurately reflects the levels of lipidated apoE.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationNeurons require substantial amounts of cholesterol to maintain their prolific dendritic extensions.
“Neurons require substantial amounts of cholesterol to maintain their prolific dendritic extensions (Yu et al., 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yu et al., 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationConflicting results concerning the role of apoE in learning and memory have been demonstrated in apoE deficient mice.
“Conflicting results concerning the role of apoE in learning and memory have been demonstrated in apoE deficient mice.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSome studies show no significant cognitive impairments in apoE deficient mice compared to either wild type or human apoE3 expressing mice.
“Some studies show no significant cognitive impairments compared to either wild type or human apoE3 expressing mice (Raber et al., 1998, Grootendorst et al., 2005, Hartman et al., 2001, van Meer et al., 2007)”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationApoE isoform specific sex differences in behavior have been previously shown.
“apoE isoform specific sex differences in behavior have been previously shown (Raber et al., 1998, Raber et al., 2000).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenThis study only involved female mice.
“It should also be noted that this study only involved female mice”
Quote in the paperNot a substantial claim
The paper relies on this without support.
LDLR has a high affinity for apoE and is the only member of its receptor family to demonstrate an apoE isoform-specific binding affinity (E4>E3>>E2).
“The low-density lipoprotein receptor (LDLR) has a high affinity for apoE, and is the only member of its receptor family to demonstrate an apoE isoform specific binding affinity (E4>E3>>E2).”
The authors state this as an assumption.
It is unclear whether apoE isoform-dependent interactions with human LDLR affect brain function.
“In contrast to cardiovascular function, it is unclear whether apoE isoform-dependent interactions with human LDLR affect brain function.”
The paper relies on this without support.
ApoE and LDLR likely play a similarly critical role in the brain as in the peripheral vasculature.
“ApoE and LDLR play critical roles in the regulation of cholesterol metabolism in the peripheral vasculature (Go and Mani, 2012) and likely play a similarly critical role in the brain.”
The paper relies on this without support.
The hippocampus is a brain region critical for performance on the water maze spatial memory task.
“a brain region critical for performance on this task”
The paper relies on this without support.
Human apoE Targeted Replacement (TR) mice are a commonly used model in the AD and CVD fields.
“as the human apoE Targeted Replacement (TR) mice are a commonly used model in the AD and CVD fields.”
The paper relies on this without support.
Both contextual fear conditioning and cued fear conditioning strongly rely on the amygdala.
“Interestingly, both of these neuropsychological processes strongly rely on the amygdala.”
The paper relies on this without support.
Trafficking of apoE-containing HDL-like particles in the brain is likely affected by interaction of apoE with the LDLR, as it is in the periphery.
“The trafficking of these HDL-like particles in the brain is likely affected by interaction of apoE with the LDLR, as it is in the periphery.”
The paper relies on this without support.
The insoluble (detergent-soluble) fraction more accurately reflects the levels of lipidated apoE.
“In this study, we limited our analyses of brain apoE to the insoluble (detergent-soluble) fraction as this preparation more accurately reflects the levels of lipidated apoE.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Claim of regulated cortical cholesterol conflicts with reported nonsignificant result
MajorThe abstract claims cortical cholesterol is regulated by isoform-dependent apoE-LDLR interactions, but Results report no significant difference by APOE genotype. The reported cholesterol measurements were also confined to mice with human LDLR, so they cannot establish an APOE × LDLR interaction for this outcome.
“Our results show that plasma and brain apoE levels, cortical cholesterol, and spatial memory are all regulated by isoform-dependent interactions between apoE and LDLR.”
“Cholesterol levels in the cortex did not significantly differ by APOE genotype. However, there was a trend towards lower cholesterol in human LDLR mice with E4 compared to human LDLR mice with E3 or E2 .”
Two different correlation results are assigned to the E3 group
MinorThe same sentence assigns E3 mice both r2 = 0.695 (p < 0.05) and r2 = 0.884 (p < 0.01) for the hippocampal apoE-probe performance correlation.
“and E3 (r2 = 0.695, p < 0.05”
“and r2 = 0.884, p < 0.01, Pearson correlation)”
Object-exposure day differs between Methods and Results
MinorMethods say mice spent the first two days habituating and first encountered the identical objects on the third day. Results say they encountered those objects on the first day of the paradigm.
“On the first day of this paradigm, mice were allowed 15 minutes to explore an open arena containing two identical (“Familiar”) objects.”
“Mice were placed into a brightly lit square arena (40.6 × 40.6 cm) and habituated to the open field arena over two days, with a one 10-minute trial per day. On the third day, mice were exposed to the arena containing two identical objects”
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Neurobiology of Pavlovian fear conditioning
Maren, S. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.897 · Cited by 1,543
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J., & Dourish, C. T. (1994) · Psychopharmacology · doi:10.1007/bf02244871 · Cited by 739
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis
Meewisse, M.-L., Reitsma, J. B., De Vries, G.-J., Gersons, B. P. R., & Olff, M. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024877 · Cited by 661
Dębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602
ApoE genotype accounts for the vast majority of AD risk and AD pathology
Raber, J., Huang, Y., & Ashford, J. W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.023 · Cited by 599
Self-citationSullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575
Self-citationObject recognition memory and the rodent hippocampus
Broadbent, N. J., Gaskin, S., Squire, L. R., & Clark, R. E. (2010) · Learning & Memory · doi:10.1101/lm.1650110 · Cited by 568
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Reelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524
Boyles, J. K., Zoellner, C. D., Anderson, L. J., Kosik, L. M., Pitas, R. E., Weisgraber, K. H., Hui, D. Y., Mahley, R. W., Gebicke-Haerter, P. J., & Ignatius, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113943 · Cited by 419
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Chen, Y., Durakoglugil, M. S., Xian, X., & Herz, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914984107 · Cited by 368
Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., Mahley, R. W., & Mucke, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10914 · Cited by 364
Self-citationImpact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 346
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., Quarfordt, S. H., Sullivan, P. M., & Maeda, N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6172 · Cited by 324
Self-citationApolipoprotein E: From lipid transport to neurobiology
Hauser, P. S., Narayanaswami, V., & Ryan, R. O. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.001 · Cited by 320
STRUCTURE AND PHYSIOLOGIC FUNCTION OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR
Jeon, H., & Blacklow, S. C. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133354 · Cited by 310
Apolipoprotein E: from atherosclerosis to Alzheimerʼs disease and beyond
Mahley, R. W., & Huang, Y. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00003 · Cited by 308
Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE ε4
Irie, F., Fitzpatrick, A. L., López, O. L., Kuller, L. H., Peila, R., Newman, A. B., & Launer, L. J. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.29 · Cited by 306
Fryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278
Self-citationThe receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276
Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 274 · cited 2×
“Furthermore, over-expression of LDLR – while increasing clearance of Aβ – results in decreased brain apoE concentrations (Kim et al., 2009), although this clearance may occur through an apoE-independent pathway (Basak et al., 2012).”
TOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272
Sullivan, P. M., Mezdour, H., Quarfordt, S. H., & Maeda, N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2673 · Cited by 264 · cited 1×
“…the apoE isoforms differentially impact the expression and function of apoE in humans and in mice (Betrand et al., 1995, Beffert et al., 1999, Fryer et al., 2005, Fukomoto et al., 2003, Glockner et al., 2002, Poirer et al., 2005, Ramaswamy et al., 2005, Riddell et al., 2008, Sullivan et al., 2004).”
Self-citationInnerarity, T. L., Pitas, R. E., & Mahley, R. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50713-4 · Cited by 246
Apolipoprotein E and cognitive performance
Raber, J., Wong, D., Yu, G.-Q., Buttini, M., Mahley, R. W., Pitas, R. E., & Mucke, L. (2000) · Nature · doi:10.1038/35006165 · Cited by 237
Self-citationApolipoprotein E synthesis in human kidney, adrenal gland, and liver
Blue, M. L., Williams, D. L., Zucker, S., Khan, S. A., & Blum, C. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.283 · Cited by 226
Bertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210
Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. M., Finn, M. B., & Holtzman, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3773-11.2011 · Cited by 204
Ruiz, J., Kouiavskaia, D., Migliorini, M., Robinson, S., Saenko, E. L., Gorlatova, N., Li, D., Lawrence, D., Hyman, B. T., Weisgraber, K. H., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500114-jlr200 · Cited by 204
Basak, J. M., Verghese, P. B., Yoon, H., Kim, J., & Holtzman, D. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288746 · Cited by 192
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Porter, V. R., Buxton, W. G., Fairbanks, L. A., Strickland, T., O'Connor, S. M., Rosenberg-Thompson, S., & Cummings, J. L. (2003) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.15.2.180 · Cited by 182
LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice
Schreyer, S. A., Vick, C. M., Lystig, T., Mystkowski, P., & LeBoeuf, R. C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e207 · Cited by 182
Extrahepatic synthesis of apolipoprotein E.
Driscoll, D. M., & Getz, G. S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34454-0 · Cited by 181
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice
Gordon, I., Grauer, E., Genis, I., Sehayek, E., & Michaelson, D. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12006-p · Cited by 172
Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y., & Huang, Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0033-12.2012 · Cited by 170
Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease
Poirier, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.003 · Cited by 170
Tai, L. M., Bilousova, T., Jungbauer, L., Roeske, S. K., Youmans, K. L., Yu, C., Poon, W. W., Cornwell, L. B., Miller, C. A., Vinters, H. V., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442103 · Cited by 165
Functions of lipoprotein receptors in neurons
Beffert, U., Stolt-Bergner, P. C., & Herz, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300017-jlr200 · Cited by 164
Brain cholesterol in normal and pathological aging
Martin, M., Dotti, C. G., & Ledesma, M. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.011 · Cited by 162
Hartman, R. E., Wozniak, D. F., Nardi, A., Olney, J. W., Sartorius, L., & Holtzman, D. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7715 · Cited by 157
Castellano, J. M., Deane, R., Gottesdiener, A. J., Verghese, P. B., Stewart, F. R., West, T., Paoletti, A. C., Kasper, T. R., DeMattos, R. B., Zlokovic, B. V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206446109 · Cited by 154
Grootendorst, J., Bour, A., Vogel, E., Kelche, C., Sullivan, P. M., Dodart, J.-C., Bales, K., & Mathis, C. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.019 · Cited by 148
Self-citationBeffert, U., Cohn, J. S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J., & Poirier, J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01894-6 · Cited by 142
The link between altered cholesterol metabolism and Alzheimer's disease
Gamba, P., Testa, G., Sottero, B., Gargiulo, S., Poli, G., & Leonarduzzi, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06513.x · Cited by 141
Volcik, K. A., Barkley, R. A., Hutchinson, R. G., Mosley, T. H., HEISS, G. M., Sharrett, A. R., Ballantyne, C. M., & Boerwinkle, E. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj202 · Cited by 135
Hippocampal Lesions Disrupt an Associative Mismatch Process
Honey, R. C., Watt, A., & Good, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02226.1998 · Cited by 124
ApoE isoform affects LTP in human targeted replacement mice
Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Ye, G. L., Sotak, M., Sullivan, P. M., Pasternak, J. F., & LaDu, M. J. (2004) · NeuroReport · doi:10.1097/00001756-200412030-00020 · Cited by 124
Self-citationSevere learning deficits in apolipoprotein E-knockout mice in a water maze task
Oitzl, M. S., Mulder, M., Lucassen, P. J., Havekes, L. M., Grootendorst, J., & de Kloet, E. R. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01448-5 · Cited by 116
Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice
Sullivan, P. M., Mace, B. E., Maeda, N., & Schmechel, D. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.011 · Cited by 113
Self-citationReduced levels of human apoE4 protein in an animal model of cognitive impairment
Sullivan, P. M., Han, B., Liu, F., Mace, B. E., Ervin, J. F., Wu, S., Koger, D., Paul, S., & Bales, K. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.011 · Cited by 113
Self-citationObesity Modulates the Association among APOE Genotype, Insulin, and Glucose in Men
Elosúa, R., Demissie, S., Cupples, L. A., Meigs, J. B., Wilson, P. W. F., Schaefer, E. J., Corella, D., & Ordovás, J. M. (2003) · Obesity Research · doi:10.1038/oby.2003.201 · Cited by 108
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
Arbonés-Mainar, J. M., Johnson, L. A., Altenburg, M. K., & Maeda, N. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.143 · Cited by 99
Self-citationMulder, M., Jansen, P. J., Janssen, B. J. A., van de Berg, W. D. J., van der Boom, H., Havekes, L. M., de Kloet, R. E., Ramaekers, F. C. S., & Blokland, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.015 · Cited by 98
Greasing the wheels of Aβ clearance in Alzheimer's Disease: The role of lipids and apolipoprotein E
Fan, J., Donkin, J., & Wellington, C. (2009) · BioFactors · doi:10.1002/biof.37 · Cited by 97
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Lefterov, I., Bookout, A., Wang, Z., Staufenbiel, M., Mangelsdorf, D., & Koldamova, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-20 · Cited by 89
Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain
Ramaswamy, G., Xu, Q., Huang, Y., & Weisgraber, K. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-05.2005 · Cited by 87
ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42
Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Blaine Stine, W., Manelli, A., Sullivan, P., Pasternak, J. F., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.011 · Cited by 82
Self-citationDore, G. A., Elias, M. F., Robbins, M. A., Elias, P. K., & Nagy, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1497-2 · Cited by 81
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice
Karagiannides, I., Abdou, R. Y., Tzortzopoulou, A., Voshol, P. J., & Kypreos, K. E. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06619.x · Cited by 80
Katsouri, L., & Georgopoulos, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021880 · Cited by 72
ApoE isoforms and measures of anxiety in probable AD patients and Apoe−/− mice
Robertson, J., Curley, J., Kaye, J., Quinn, J., Pfankuch, T., & Raber, J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.003 · Cited by 71
Self-citationFukumoto, H., Ingelsson, M., Gårevik, N., Wahlund, L.-O., Nukina, N., Yaguchi, Y., Shibata, M., Hyman, B. T., Rebeck, G. W., & Irizarry, M. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00088-8 · Cited by 63
Cao, G., Bales, K., DeMattos, R., & Paul, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362173 · Cited by 60
Apolipoprotein E isoform‐specific binding to the low‐density lipoprotein receptor
Yamamoto, T., Choi, H. W., & Ryan, R. O. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.005 · Cited by 59
Freeman, T., Roca, V., Guggenheim, F., Kimbrell, T. A., & Griffin, W. S. T. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.4.541 · Cited by 59
Zou, F., Gopalraj, R. K., Lok, J., Zhu, H., Ling, I.-F., Simpson, J. F., Tucker, H. M., Kelly, J. F., Younkin, S. G., Dickson, D. W., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm365 · Cited by 58
Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
Sima, A. V., Iordan, A., & Stancu, C. S. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.258 · Cited by 57
Obesity and Alcohol Modulate the Effect of Apolipoprotein E Polymorphism on Lipids and Insulin
Marques-Vidal, P. M., Bongard, V., Ruidavets, J., Fauvel, J., Hanaire, H. P., Perret, B., & Ferrières, J. (2003) · Obesity Research · doi:10.1038/oby.2003.165 · Cited by 56
Genetic association of low density lipoprotein receptor and Alzheimer's disease
Gopalraj, R. K., Zhu, H., Kelly, J. F., Mendiondo, M., Pulliam, J. F., Bennett, D. A., & Estus, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.001 · Cited by 51
Kim, T. Y., Chung, H. G., Shin, H.-S., Kim, S. J., Choi, J. H., Chung, M. Y., An, S. K., Choi, T. K., So, H. S., & Cho, H. S. (2013) · Depression and Anxiety · doi:10.1002/da.22138 · Cited by 49
Oh, J., & Barrett-Connor, E. L. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600207.x · Cited by 49
Proposed mechanism for lipoprotein remodelling in the brain
Yu, C., Youmans, K. L., & LaDu, M. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.001 · Cited by 49
Potential genetic markers of sporadic Alzheimerʼs dementia
Retz, W., Thome, J., Durany, N., Harsányi, A., Retz-Junginger, P., Kornhuber, J., Riederer, P., & Rösler, M. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200109000-00002 · Cited by 48
Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.
Veinbergs, I., Mallory, M., Mante, M., Rockenstein, E., Gilbert, J. R., & Masliah, E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00243-8 · Cited by 46
Impairments in spatial memory retention of GFAP-apoE4 female mice
VANMEER, P., Acevedo, S. F., & Raber, J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.024 · Cited by 45
Self-citationThe association between insulin and low-density lipoprotein receptors
Ramakrishnan, G., Arjuman, A., Suneja, S., Das, C. R., & Chandra, N. C. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111430243 · Cited by 45
Role of apolipoprotein E in anxiety
Raber, J. (2007) · Neural Plasticity · doi:10.1155/2007/91236 · Cited by 44
Self-citationAbisambra, J. F., Fiorelli, T., Padmanabhan, J., Neame, P., Wefes, I., & Potter, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008556 · Cited by 42
Altenburg, M. K., Arbonés-Mainar, J. M., Johnson, L. A., Wilder, J., & Maeda, N. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164863 · Cited by 38
Self-citationHarmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3
Malloy, S. I., Altenburg, M. K., Knouff, C., Lanningham-Foster, L., Parks, J. S., & Maeda, N. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000094963.07902.fb · Cited by 37
Self-citationGlöckner, F., Meske, V., & Ohm, T. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00178-1 · Cited by 36
ApoE isoform‐dependent deficits in extinction of contextual fear conditioning
Olsen, R. H. J., Agam, M., Davis, M. J., & Raber, J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00833.x · Cited by 35
Self-citationAltenburg, M., Johnson, L., Wilder, J., & Maeda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610712200 · Cited by 34
Self-citationFunctional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease
Cheng, D., Huang, R., Lanham, I. S., Cathcart, H. M., Howard, M., Corder, E. H., & Poduslo, S. E. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024968 · Cited by 33
Association of the low-density lipoprotein receptor gene with obesity in Native American populations
Mattevi, V. S., Coimbra, C. Ε. A., Santos, R. V., Salzano, F. M., & Hutz, M. H. (2000) · Human Genetics · doi:10.1007/s004390000299 · Cited by 29
Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4
Arbonés-Mainar, J. M., Johnson, L. A., Altenburg, M. K., Kim, H., & Maeda, N. (2010) · The FASEB Journal · doi:10.1096/fj.10-159517 · Cited by 29
Self-citationKnouff, C., Malloy, S., Wilder, J., Altenburg, M. K., & Maeda, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009423200 · Cited by 28
Self-citationKornecook, T. J., McKinney, A. P., Ferguson, M. T., & Dodart, J. ‐. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00545.x · Cited by 27
Versmissen, J., Oosterveer, D. M., Hoekstra, M., Out, R., Berbée, J. F. P., Blommesteijn-Touw, A. C., der Zee, L. V. V., Vongpromek, R., Vanmierlo, T., Defesche, J. C., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.959858 · Cited by 20
(2004) · doi:10.1016/j.bbalip.2004.03.004 · Cited by 17
Self-citationHuang, Z., Maeda, N., & Mazzone, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017160 · Cited by 16
Self-citation(2011) · Neuromethods · doi:10.1007/978-1-61779-111-6 · Cited by 16
Kota, L. N., Shankarappa, B. M., Shivakumar, P., Sadanand, S., Bagepally, B. S., Krishnappa, S. B., Purushottam, M., Sivakumar, P. T., Jain, S., Varghese, M., et al. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/702972 · Cited by 13
Johnson, L. A., Kim, H.-S., Knudson, M. J., Nipp, C. T., Yi, X., & Maeda, N. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m031435 · Cited by 13
Self-citationAnxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers
Stonnington, C. M., Locke, D. E. C., Dueck, A. C., & Caselli, R. J. (2011) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.23.3.jnp294 · Cited by 8
Assessment and Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease
Gustavson, A. R., & Cummings, J. L. (2004) · Alzheimer’s Disease · doi:10.1007/978-1-59259-661-4_41 · Cited by 1
(2012) · Europe PMC (PubMed Central)
Assessment and Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease
Gustavson, A. R., & Cummings, J. L. (n.d.) · Alzheimer's Disease · doi:10.1385/1-59259-661-4:371
Flagged first, then by citations
Research works printed but not linked: 1
- Knouff, 2004, Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor, Biochim. Biophys. Acta, 1684, 8-1
Cited by
Sorted by citations
Jeremic, D., Jiménez-Díaz, L., & Navarro-López, J. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101496 · Cited by 306
Tudorache, I. F., Trusca, V. G., & Gafencu, A. V. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.05.003 · Cited by 186
Apolipoprotein E and Alzheimer's disease
Troutwine, B., Hamid, L., Lysaker, C. R., Strope, T. A., & Wilkins, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.002 · Cited by 177
Whole-genome sequencing analysis of the cardiometabolic proteome
Gilly, A., Park, Y.-C., Png, G., Barysenka, A., Fischer, I., Bjørnland, T., Southam, L., Suveges, D., Neumeyer, S., Rayner, N. W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20079-2 · Cited by 107
Destabilizing heterochromatin by APOE mediates senescence
Zhao, H., Ji, Q., Wu, Z., Wang, S., Ren, J., Yan, K., Wang, Z., Hu, J., Chu, Q., Hu, H., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00186-z · Cited by 104
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00483-y · Cited by 87
Self-citationThe benefit of docosahexaenoic acid for the adult brain in aging and dementia
Salem, N., Vandal, M., & Calon, F. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.10.003 · Cited by 86
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
Rhea, E. M., Banks, W. A., & Raber, J. (2022) · Biomedicines · doi:10.3390/biomedicines10071582 · Cited by 76
Self-citationMcGinnis, G. J., Friedman, D. J., Young, K. H., Torres, E. R. S., Thomas, C. R., Gough, M. J., & Raber, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13551 · Cited by 75
Self-citationMiranda, C. L., Johnson, L. A., de Montgolfier, O., Elias, V. D., Ullrich, L. S., Hay, J. J., Paraiso, I. L., Choi, J., Reed, R. L., Revel, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18992-6 · Cited by 75
Self-citationAddressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 71
ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations
Johnson, L. A., Zuloaga, D. G., Bidiman, E., Marzulla, T., Weber, S., Wahbeh, H., & Raber, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.95 · Cited by 69
Self-citationAlzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
Fox, M. M., Knorr, D. A., & Haptonstall, K. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14129 · Cited by 67
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N. C. D. F., Mirfakhar, F. S., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 65
Integrating Multisource Block-Wise Missing Data in Model Selection
Xue, F., & Qu, A. (2020) · Journal of the American Statistical Association · doi:10.1080/01621459.2020.1751176 · Cited by 61
Winkle, C. C., Olsen, R. H. J., Kim, H., Moy, S. S., Song, J., & Gupton, S. L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3876-15.2016 · Cited by 59
Self-citationApoE and cerebral insulin: Trafficking, receptors, and resistance
Rhea, E. M., Raber, J., & Banks, W. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104755 · Cited by 50
Self-citationFocused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients
Karakatsani, M. E., Ji, R., Murillo, M. F., Kugelman, T., Kwon, N., Lao, Y., Liu, K., Pouliopoulos, A. N., Honig, L. S., Duff, K., et al. (2023) · Theranostics · doi:10.7150/thno.79898 · Cited by 47
Abbas, K., Mustafa, M., Alam, M., Habib, S., Ahmad, W., Adnan, M., Hassan, M. I., & Usmani, N. (2025) · Neurogenetics · doi:10.1007/s10048-025-00821-y · Cited by 46
Gene–gene interaction detection with deep learning
Cui, T., Mekkaoui, K. E., Reinvall, J., Havulinna, A. S., Marttinen, P., & Samuel Kaski, A. (2022) · Communications Biology · doi:10.1038/s42003-022-04186-y · Cited by 42
Adipocyte function and the development of cardiometabolic disease
Giroud, M., Jodeleit, H., Prentice, K. J., & Bartelt, A. (2021) · The Journal of Physiology · doi:10.1113/jp281979 · Cited by 42
McCormack, T., Dent, R., & Blagden, M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12881 · Cited by 39
Passarella, D., Ciampi, S., Liberto, V. D., Zuccarini, M., Ronci, M., Medoro, A., Foderà, E., Frinchi, M., Mignogna, D., Russo, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168921 · Cited by 38
Do, H. T., Bruelle, C., Pham, D. D., Jauhiainen, M., Eriksson, O., Korhonen, L. T., & Lindholm, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13397 · Cited by 37
Valkenburgh, J. S. V., Meuret, C. J., Martinez, A. E., Kodancha, V., Solomon, V. A., Chen, K., & Yassine, H. N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.700847 · Cited by 37
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01686-8 · Cited by 34
APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses
Friday, C. M., Stephens, I. O., Smith, C. T., Lee, S., Satish, D., Devanney, N. A., Cohen, S., Morganti, J. M., Gordon, S. M., & Johnson, L. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106983 · Cited by 33
Self-citationHurley, M. J., Deacon, R. M. J., Beyer, K., Ioannou, E., Ibáñez, A. M., Teeling, J. L., & Cogram, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.001 · Cited by 32
Vuu, Y. M., Shahib, A. K., & Rastegar, M. (2023) · Pharmaceuticals · doi:10.3390/ph16070914 · Cited by 31
Human apolipoprotein E as a reservoir of cryptic bioactive peptides: The case of ApoE 133‐167
Zanfardino, A., Bosso, A., Gallo, G., Pistorio, V., Napoli, M. D., Gaglione, R., Dell’Olmo, E., Varcamonti, M., Notomista, E., Arciello, A., et al. (2018) · Journal of Peptide Science · doi:10.1002/psc.3095 · Cited by 29
Boutros, S. W., Raber, J., & Unni, V. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212566 · Cited by 27
Self-citationVillasana, L., Weber, S. J., Akinyeke, T. O., & Raber, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13737 · Cited by 27
Self-citationRomano, S., Mitro, N., Giatti, S., Diviccaro, S., Pesaresi, M., Spezzano, R., Audano, M., García‐Segura, L. M., Caruso, D., & Melcangi, R. C. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.11.009 · Cited by 27
Innes, H. A., Nischalke, H. D., Guha, I. N., Weiss, K. H., Irving, W. L., Gotthardt, D. N., Barnes, E. J., Fischer, J., Ansari, M. A., Rosendahl, J., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1886 · Cited by 24
Na, H., Yang, J. B., Zhang, Z., Gan, Q., Tian, H., Rajab, I. M., Potempa, L. A., Tao, Q., & Qiu, W. Q. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.02.013 · Cited by 27
Protective ApoE variants support neuronal function by effluxing oxidized phospholipids
Ralhan, I., Do, A. D., Bae, J.-Y., Feringa, F. M., Cai, W., Chang, J., Chik, K., Lee, N. Y. J., Gerry, C. J., van der Kant, R., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.10.040 · Cited by 23
Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer’s Disease
Patra, K., Giannisis, A., Edlund, A. K., Sando, S. B., Lauridsen, C., Berge, G., Grøntvedt, G. R., Bråthen, G., White, L. R., & Nielsen, H. M. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190175 · Cited by 22
Goodenowe, D. B., & Senanayake, V. K. (2019) · Brain Sciences · doi:10.3390/brainsci9040092 · Cited by 22
Lipid metabolism in tumor-infiltrating T cells: mechanisms and applications
Ke, X., Zou, M.-W., & Xu, C. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac038 · Cited by 21
Ni, J., Chen, C., Wang, S., Liu, X., Tan, L., Li, L., Fan, Y., Hou, Y., Dou, H., & Liang, J. F. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03146-z · Cited by 20
Chandra, N. C. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22840 · Cited by 20
Golden, L. R., Siano, D. S., Stephens, I. O., MacLean, S. M., Saito, K., Nolt, G. L., Funnell, J. L., Pallerla, A. V., Lee, S., Smith, C., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02094-y · Cited by 18
Self-citationBruno, F., Camuso, S., Capuozzò, E., & Canterini, S. (2023) · Antibiotics · doi:10.3390/antibiotics12010122 · Cited by 18
Segev, Y., Livne, A., Mints, M., & Rosenblum, K. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00170 · Cited by 18
Low-Density Lipoprotein Receptor Contributes to β-Carotene Uptake in the Maternal Liver
Shete, V., Costabile, B. K., Kim, Y.-K., & Quadro, L. (2016) · Nutrients · doi:10.3390/nu8120765 · Cited by 18
Rashidi, O. M., H.Nazar, F. A., Alama, M. N., & Awan, Z. A. (2017) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401711010084 · Cited by 17
Nielsen, D. A., Spellicy, C. J., Harding, M. J., & Graham, D. P. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.013 · Cited by 17
Kang, S., Lee, J., Ali, D. N., Choi, S. H., Nesbitt, J. J., Min, H.-K. P., Trushina, E. V., & Choi, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-75202-w · Cited by 16
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer’s Disease: A Literature Review
Grao‐Cruces, E., Claro, C., la Paz, S. M., & Nóbrega, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032944 · Cited by 15
APOE genotype dictates lipidomic signatures in primary human hepatocytes
Almeida, F., Patra, K., Giannisis, A., Niesnerova, A., Nandakumar, R., Ellis, E. C. S., Oliveira, T. G., & Nielsen, H. M. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100498 · Cited by 15
Desai, D. A., Schmidt, S., & Cristofoletti, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1454785 · Cited by 15
Petty, H. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00032 · Cited by 15
Novel apoE receptor mimetics reduce LPS-induced microglial inflammation.
(2019) · Europe PMC (PubMed Central) · Cited by 15
Huang, H.-J., Chen, H., Lee, C.-C., & Chen, C. Y. (2014) · BioMed Research International · doi:10.1155/2014/452625 · Cited by 15
In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer’s Disease Therapy
Bano, S., Rasheed, M. A., Jamil, F., Ibrahim, M. K., & Kanwal, S. (2018) · Current Computer - Aided Drug Design · doi:10.2174/1573409914666181008164209 · Cited by 13
Zang, F., Liu, X., Fan, D., He, C., Zhang, Z., Xie, C., & Initiative, A. D. N. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70029 · Cited by 12
TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway
Yang, N. V., Chao, J. Y., Garton, K. A., Tran, T., King, S. M., Orr, J., Oei, J. H., Crawford, A. P., Kang, M., Zalpuri, R., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102056 · Cited by 12
He, Y., Sun, L., Bai, X., Cai, B., Tu, Z., Chen, F., Bian, Y., Zhang, X., Han, X., Lv, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54519-0 · Cited by 12
Potempa, L. A., Qiu, W. Q., Stefanski, A., & Rajab, I. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.979461 · Cited by 12
Perks, C. M., Barker, R. M., Alhadrami, M., Alkahtani, O., Gill, E., Grishaw, M., Harland, A. J., Henley, P., Li, H., O’Sullivan, E., et al. (2025) · Genes · doi:10.3390/genes16030331 · Cited by 11
Hypercholesterolemia drives microglial dysfunction and weakens response to amyloid plaques
Kaye, S. D., Gold, A., Lin, D., Chen, M., Zhu, J., & Gao, J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115272 · Cited by 11
Zhang, M., Van, L. M., & Amiji, M. M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102686 · Cited by 11
Zuloaga, D. G., Johnson, L. A., Weber, S. J., & Raber, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4114-8 · Cited by 11
Self-citationApoE Genotype-Dependent Response to Antioxidant and Exercise Interventions on Brain Function
Chaudhari, K., Wong, J. M., Vann, P. H., Como, T., O’Bryant, S. E., & Sumien, N. (2020) · Antioxidants · doi:10.3390/antiox9060553 · Cited by 9
Boutros, S. W., Krenik, D., Holden, S. J., Unni, V. K., & Raber, J. (2022) · Oncotarget · doi:10.18632/oncotarget.28180 · Cited by 9
Self-citationKoesema, E., & Kodadek, T. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188082 · Cited by 8
New APOE-related therapeutic options for Alzheimer’s disease
Li, Z. (2019) · AIP conference proceedings · doi:10.1063/1.5085515 · Cited by 8
LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice
Stukas, S., Freeman, L., Lee, M., Wilkinson, A., Ossoli, A., Vaisman, B., Demosky, S., Chan, J., Hirsch-Reinshagen, V., Remaley, A. T., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m049940 · Cited by 9
Investigation of factors affecting students' satisfaction with online course components.
Qureshi, E. (2004) · Scholarship at UWindsor (University of Windsor) · Cited by 8
Luckhoff, H. K., Kidd, M., van Rensburg, S. J., van Velden, D. P., & Kotze, M. J. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9737-2 · Cited by 7
Radiation neurobiology of long-term spaceflights
Олегович, С. А., Ушаков, И. Б., Sapetsky, N. V., Shtemberg, A. S., Kositsin, N. S., & Timofeev, N. N. (2017) · Biology Bulletin Reviews · doi:10.1134/s2079086417060068 · Cited by 6
Liemisa, B., Newbury, S. F., Novy, M. J., Pasato, J., Morales‐Corraliza, J., Peng, K. Y., & Mathews, P. M. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100102 · Cited by 5
APOE genotype and biological age impact inter-omic associations related to bioenergetics
Ellis, D., Watanabe, K., Wilmanski, T. M., Lustgarten, M. S., Korat, A. V. A., Glusman, G., Hadlock, J., Fiehn, O., Sebastiani, P., Price, N. D., et al. (2025) · Aging · doi:10.18632/aging.206243 · Cited by 5
Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice
Watson, Y., Nelson, B., Kluesner, J. H., Tanzy, C., Ramesh, S., Patel, Z., Kluesner, K. H., Singh, A., Murthy, V., & Mitchell, C. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210492 · Cited by 5
Vartiainen, E., Liyanage, D., Mazureac, I., Battaglia, R. A., Tegtmeyer, M., Xu, H. J., Räsänen, N., Sealock, J., McCarroll, S. A., Nehme, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.28.635252 · Cited by 5
Protective ApoE variants support neuronal function by extracting peroxidated lipids
Ralhan, I., Do, A. D., Bae, J.-Y., Feringa, F. M., Cai, W., Chang, J., Chik, K., Lee, N. Y., Gerry, C., van der Kant, R., et al. (2025) · bioRxiv · doi:10.1101/2025.03.05.641722 · Cited by 4
Verma, S., Malviya, R., Sundaram, S., Srivastava, S., Sridhar, S. B., Rab, S. O., & Singh, D. P. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266327892241223052456 · Cited by 4
Huang, Y., Chan, H., Khoo, J.-Y., Chan, M.-L., Bender, D. A., Ponnusamy, V. K., Belaidi, A. A., & Ke, L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106104 · Cited by 4
Колесникова, И. А., Lalkovičová, M., Severiukhin, Y. S., Golikova, K. N., Utina, D. M., Pronskikh, E. V., Despotović, S. Z., Gaevsky, V. N., Pirić, D., Masnikosa, R., et al. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01381-1 · Cited by 4
Bagaria, J., Moon, Y., Bagyinszky, E., Shim, K. H., An, S. S. A., Kim, S., & Han, S. H. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.899644 · Cited by 4
Lambart, I., Zaryouh, H., Audenaerde, J. R. M. V., Liu, D., Quatannens, D., Lion, E., Schiller, S., Geißler, S., Smits, E., & Mäder, K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125720 · Cited by 3
Marmunti, M., Gavazza, M., & Palacios, A. (2021) · Revista de la Facultad de Medicina Veterinaria y de Zootecnia · doi:10.15446/rfmvz.v68n1.97189 · Cited by 3
Patil, S. P., DiFlumeri, J., Wellington, J., Fattakhova, E., & Oravic, M. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110865 · Cited by 3
Imaging Biomarkers for Alzheimer's Disease Using Magnetic Resonance Microscopy
Badea, A., Stout, J. A., Anderson, R. J., Cofer, G. P., Duan, L. L., & Vogelstein, J. T. (2022) · Wiley eBooks · doi:10.1002/9783527827244.ch13 · Cited by 2
Chen, H., Zhang, H., Yang, M., Xie, Q., & Zhu, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261416064 · Cited by 1
Wang, N., Yu, G., Wang, Z., Alnobani, A., Jeevaratnam, S., Zhang, X., McReynolds, M. G., Chang, Y., Qi, F., Tauer, W., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00940-6 · Cited by 1
Gonzalez, B. L. (2016) · eScholarship (California Digital Library)
Strattan, L. E. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.097
Song, Z., Huang, X., Jannu, A. J., Johnson, T. S., Zhang, J., & Huang, K. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.077551
Unveiling the Nexus Between the APOE Gene and Anxiety/Depression: A Comprehensive Review
Xu, C. D., Gamez, D., Saveron, J. M., Guajardo, E., Su, B., & Wang, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_9-1
Zhang, G. (2025) · Environmental Disease · doi:10.4103/ed.ed_5_25
Unveiling the Nexus Between the APOE Gene and Anxiety/Depression: A Comprehensive Review
Xu, C. D., Gamez, D., Saveron, J. M., Guajardo, E., Su, B., & Wang, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_9
In Silico Design of APOE ɛ4 Interaction Inhibitor Peptides for Alzheimer’s DiseasePreprint
Ji, J., Han, E., Park, J., Son, A., & Kim, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.03.673973
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575414
Self-citationNi, J., Chen, C., Wang, S., Liu, X., Tan, L., Lu, L., Fan, Y., Hou, Y., Dou, H., & Liang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26615767
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730970
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730961
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730964
Ni, J., Chen, C., Wang, S., Liu, X., Tan, L., Lu, L., Fan, Y., Hou, Y., Dou, H., & Liang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26615773
Ni, J., Chen, C., Wang, S., Liu, X., Tan, L., Lu, L., Fan, Y., Hou, Y., Dou, H., & Liang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26615770
Metadata
- Authors
- Johnson, L. A., Olsen, R. H. J., Merkens, L. S., DeBarber, A., Steiner, R. D., Sullivan, P. M., Maeda, N., & Raber, J.
- Affiliations
- Oregon Health & Science University (US)
- Duke University (US)
- University of North Carolina at Chapel Hill (US)
- Oregon National Primate Research Center (US)
- Corresponding author
- Raber, Jacob
- ORCID
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 64
- Pages
- 150-162
- ISSN
- 0969-9961 (ISSN-L)
- PMC
- PMC3936477
- OpenAlex
- W1985410153
- Cited by
- 107
- References
- 110
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 11 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 3
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UNC Libraries
- Funders
- National Institute of Environmental Health Sciences (T32-ES07060)
- National Heart, Lung, and Blood Institute (T32-HL094294)
- Collins Medical Trust
- Oregon Tax Check-off Program for Alzheimer's Research administered by the Layton Aging & Alzheimer's Disease Center, Oregon Health & Science University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, APOE isoforms, LDL receptor, spatial memory, brain cholesterol, hippocampus, Alzheimer's disease risk, cardiovascular risk, anxiety-like behavior, transgenic mice
- MeSH terms
- Animals, Anxiety, Apolipoproteins E, Brain, Cholesterol, Conditioning, Psychological, Humans, Memory, Mice, Inbred C57BL, Mice, Transgenic, Receptors, LDL, Space Perception, Mice, Knockout, Mice, Apolipoprotein E3, Apolipoprotein E4, Apolipoprotein E2, Memory, Long-Term
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review